Myeloid differentiation primary response protein 88 (MyD88) is a critical adaptor protein involved in Toll-like receptor (TLR) and interleukin-1 (IL-1) receptor family signaling controlling innate immune responses and inflammation. MyD88 links IL-1 receptor (IL-1R) or TLR family members to IL-1R-associated kinase (IRAK) family kinases via homotypic protein-protein interaction. Activation of IRAK family kinases leads to a variety of functional outputs, including the activation of nuclear factor-kappa B (NFκB), mitogen-activated protein kinases, and activator protein 1, making MyD88 a central node of inflammatory pathways. Genetic deletion of MyD88 function results in profound suppression of inflammation and reduced resistance of the host to pathogens indicating non-redundant roles of MyD88. Detection of MyD88 expression was to predict the prognosis of various human cancers, e.g., lymphoid, liver, and colorectal cancers.
Full Name
myeloid differentiation primary response 88
Research Areas
- Apoptosis Adaptor Proteins
- Adaptor Proteins
References
- Wang L, et al. (2018) Dual functional roles of the myd88 signaling in colorectal cancer development. Biomed Pharmacother 107 177-184.
- Gallot YS, et al. (2018) Myd88 is required for satellite cell-mediated myofiber regeneration in dystrophin-deficient mdx mice. Hum Mol Genet 27 (19): 3449-3463.
- Di Padova F, et al. (2018) Myd88 as a therapeutic target for inflammatory lung diseases. Expert Opin Ther Targets 22 (5): 401-408.
- Deguine J, et al. (2014) Myd88: A central player in innate immune signaling. F1000Prime Rep 6 97.